₹1,085.80 12.80 (1.19%)
17-Jan-2025₹1,084.35 6.15 (0.57%)
17-Jan-2025BSE : 543322
NSE : GLS
Sector : Health care
ISIN Code : INE03Q201024
Last Updated: 17-Jan-2025
Market Cap (₹ Cr) | 13,306 |
Traded Value (₹ Cr) | 1.23 |
Volume (Shares) | 11,298 |
Face Value (₹) | 2 |
52-Week High (₹) | 1,335.00 |
52-Week High Date | 16-Sep-2024 |
52-Week Low (₹) | 666.05 |
52-Week Low Date | 14-Mar-2024 |
All Time High (₹) | 1,335.00 |
All Time High Date | 16-Sep-2024 |
All Time Low (₹) | 369.00 |
All Time Low Date | 22-Feb-2023 |
₹Stock Market LIVE:Sensex down 200 pts at 79,000; India Dec Svcs PMI Final at 59.3, from 58.4 before
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 13,289 |
EPS - TTM (₹) [C] | 28.69 |
P/E Ratio (X) [C] | 37.80 |
Face Value (₹) | 2 |
Latest Dividend (%) | 1,125.00 |
Latest Dividend Date | 17-Oct-2023 |
Dividend Yield (%) | 4.82 |
Book Value Share (₹) [C] | 147.95 |
P/B Ratio (₹) [C] | 7.33 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
Quant Flexi Cap Fund (G) | 107.02 | 10,88,244 | 1.49 |
Quant Flexi Cap Fund (IDCW) | 107.02 | 10,88,244 | 1.49 |
Quant Flexi Cap Fund - Direct (IDCW) | 107.02 | 10,88,244 | 1.49 |
Quant Flexi Cap Fund - Direct (G) | 107.02 | 10,88,244 | 1.49 |
Tata Small Cap Fund - Direct (IDCW) RI | 61.75 | 6,27,903 | 0.64 |
Tata Small Cap Fund - Regular (IDCW) RI | 61.75 | 6,27,903 | 0.64 |
Tata Small Cap Fund - Direct (IDCW) | 61.75 | 6,27,903 | 0.64 |
Tata Small Cap Fund - Direct (G) | 61.75 | 6,27,903 | 0.64 |
Tata Small Cap Fund - Regular (IDCW) | 61.75 | 6,27,903 | 0.64 |
Tata Small Cap Fund - Regular (G) | 61.75 | 6,27,903 | 0.64 |
Load more
Today's Low/High (₹) | 1,056.80 1,095.00 |
Week Low/High (₹) | 968.05 1,095.00 |
Month Low/High (₹) | 940.15 1,095.00 |
Year Low/High (₹) | 676.50 1,335.00 |
All time Low/High (₹) | 369.00 1,335.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | 7.24% | 7.24% | -0.98 | -0.97% |
1 Month | 7.05% | 7.17% | -5.04 | -4.65% |
3 Month | -3.47% | -3.66% | -5.42 | -6.25% |
6 Month | 26.97% | 26.81% | -5.08 | -5.73% |
1 Year | 44.43% | 44.26% | 7.16 | 7.56% |
3 Year | 78.70% | 78.63% | 24.97 | 26.74% |
Managing Director & CEO : Yasir Yusufali Rawjee
Executive Director : Vinod Naik
Independent Non Exe. Director : Manju Agarwal
Independent Non Exe. Director : Taruvai Laxminarayanan Easwar
Chairman (Non-Executive) : HIREN KARSANBHAI PATEL
Independent Director : KAUSHIKBHAI NANDUBHAI PATEL
Independent Director : VIJAYKUMAR RATILAL SHAH
Independent Director : Savan Godialwala
Company Sec. & Compli. Officer : Rudalf Corriea
Registered Office: Plot No. 170-172 Chandramouli, Industrial Est.Mohol Bazarpeth,Solapur,Maharashtra-413213 Ph: 91-2189-234456/234246
1. What's the Alivus Life Sciences Ltd share price today?
Alivus Life Sciences Ltd share price was Rs 1,085.80 at close on 17th Jan 2025. Alivus Life Sciences Ltd share price was up by 1.19% over the previous closing price of Rs 1,073.00. Alivus Life Sciences Ltd share price trend:
2. How can I quickly analyse the performance of the Alivus Life Sciences Ltd stock?
The performance of the Alivus Life Sciences Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Alivus Life Sciences Ltd?
Alivus Life Sciences Ltd has a market capitalisation of Rs 13,306 crore.
4. What is Alivus Life Sciences Ltd's 52-week high/low share price?
The Alivus Life Sciences Ltd’s 52-week high share price is Rs 1,335.00 and 52-week low share price is Rs 666.05.
5. Is the Alivus Life Sciences Ltd profitable?
On a consolidated basis, Alivus Life Sciences Ltd reported a profit of Rs 95.32 crore on a total income of Rs 515.41 crore for the quarter ended 2024. For the year ended Sep 2024, Alivus Life Sciences Ltd had posted a profit of Rs 95.32 crore on a total income of Rs 515.41 crore.
6. Which are Alivus Life Sciences Ltd’s peers in the Health care sector?
Alivus Life Sciences Ltd’s top 5 peers in the Health care sector are Jubilant Pharmo, Sai Life, Granules India, Alivus Life, Sanofi India, Marksans Pharma, Sanofi Consumer.
7. Who owns how much in Alivus Life Sciences Ltd?
Key changes to the Alivus Life Sciences Ltd shareholding are as follows: